Home
>
National Drug Code (NDC)
>
QNASL
QNASL - 59310-210-14 - (beclomethasone dipropionate)
Drug Information of QNASL
| Product NDC: | 59310-210 |
| Proprietary Name: | QNASL |
| Non Proprietary Name: | beclomethasone dipropionate |
| Active Ingredient(s): | 80 ug/1 & nbsp; beclomethasone dipropionate |
| Administration Route(s): | NASAL |
| Dosage Form(s): | AEROSOL, METERED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of QNASL
| Product NDC: | 59310-210 |
| Labeler Name: | Teva Respiratory, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA202813 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120405 |
Package Information of QNASL
| Package NDC: | 59310-210-14 |
| Package Description: | 120 AEROSOL, METERED in 1 INHALER (59310-210-14) |
NDC Information of QNASL
| NDC Code | 59310-210-14 |
| Proprietary Name | QNASL |
| Package Description | 120 AEROSOL, METERED in 1 INHALER (59310-210-14) |
| Product NDC | 59310-210 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | beclomethasone dipropionate |
| Dosage Form Name | AEROSOL, METERED |
| Route Name | NASAL |
| Start Marketing Date | 20120405 |
| Marketing Category Name | NDA |
| Labeler Name | Teva Respiratory, LLC |
| Substance Name | BECLOMETHASONE DIPROPIONATE |
| Strength Number | 80 |
| Strength Unit | ug/1 |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
